Breaking News

One step closer to treating AMD

Scientists at the University of Birmingham, UK, are one step closer to developing an eye drop that could revolutionise ...

Hikma acts to ease critical shortage of pain medications in the US

Injectable opioids levels have decreased significantly since a supplier to the US market temporarily ceased ...

Xbrane and STADA enter into a co-development agreement for Xlucane

Via a 50/50 split of expenses and profits, the companies will equally contribute to the development of Xlucane, a ...

Vitreoretinal diseases Ė ocriplasmin

If the attachment between vitreous and the retina strengthens abnormally, it can threaten sight via conditions such as ...

Real-time medication management technology

Aptar Pharma and Kali Care develop technology to address the challenge of monitoring adherence in ophthalmic clinical ...

Clinigen launches Japanese business to strengthen Asian presence

Clinigen is a global pharmaceutical and services company with a unique combination of businesses focused on providing ...

Bayer and DelSiTech link up to develop new ophthalmology drug delivery technology

Agreement highlights the potential of biodegradable silica material in demanding drug delivery applications

Nicox to transfer commercial operations to new company led by GHO Capital

The deal values Nicox's operations at up to Ä26m

Behcetís uveitis Ė gevokizumabn

BehÁetís disease causes severe non-infectious uveitis in about half of all patients and if not treated rapidly, can ...

US FDA grants priority review for Nicox's AC-170 new drug application

FDA assigns Prescription Drug User Fee Act (PDUFA) goal date of 18 October 2016

Almac Discovery, McClay Foundation and Ulster University join forces to explore diseases of the eye

In a two-year project, the participants will investigate the effects of the protein FKBP-L on eye diseases